Saturday 17 October 2026
Export NVCR’s income statement to Excel — free account
NovoCure Limited
NVCR Healthcare Medical Devices
NovoCure Limited’s revenue for fiscal 2025 (year ended December 2025) was $655.4 million, up 8.28% from fiscal 2024. In the quarter to June 2026, revenue grew 15.6%, EPS grew 63.9%, free cash flow grew 105.7% and total debt rose 100.7%, each against the same quarter a year earlier.
14.07
0.34
−2.36%
Follow NVCR
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
3 | 4 | 3 | 3 |
| (50.60%) | (38.89%) | (49.96%) | (43.22%) | ||
| (13.75%) | (13.32%) | (16.99%) | (14.56%) | ||
ROIC |
0.00% | (123.24%) | (92.52%) | (115.56%) | |
Return on Tangible Assets |
(33.88%) | (26.04%) | (33.69%) | (28.58%) | |
Average Days of Receivables |
70.88 | 82.49 | 79.24 | 76.12 | |
Free Cash Flow per Share |
(0.58) | (0.68) | (0.42) | (0.22) | |
Free Cash Flow |
(65.17) | (75.68) | (48.07) | (25.43) | |
Capital Expenditures |
(30.69) | (26.65) | (21.19) | (22.62) | |
| Other line items | |||||
Cash ROIC |
(4.15%) | (7.62%) | (4.77%) | (2.58%) | |
Accounts Receivable Turnover |
5.91 | 5.09 | 5.09 | 5.09 | |
Accounts Payable Turnover |
1.50 | 1.47 | 1.50 | 1.42 | |
Inventory Turnover |
4.05 | 4.38 | 4.03 | 4.05 | |
Average Days of Payables |
274.40 | 267.35 | 277.62 | 285.86 | |
Days of Inventory on Hand |
90.23 | 89.92 | 94.82 | 92.33 | |
Tax Rate |
0.18 | 0.00 | (0.01) | (0.03) | |
Research and Development Expense of Revenue |
33.45% | 34.26% | 33.97% | 32.14% | |
Selling, General and Administrative Expense of Revenue |
69.43% | 63.74% | 68.41% | 66.07% | |
Share Based Compensation of Revenue |
23.01% | 16.00% | 20.51% | 18.47% | |
Interest Coverage |
6.74 | 8.76 | 22.52 | 90.29 | |
Operating CF/Net income |
0.19 | 0.36 | 0.16 | 0.02 | |
Depreciation/Fixed assets |
(0.13) | (0.09) | (0.04) | 0.01 | |
Capex/Depreciation |
2.43 | 3.09 | 5.61 | (23.71) | |
Revenue per Share |
5.74 | 5.88 | 5.91 | 6.03 | |
Operating CF per Share |
(0.31) | (0.44) | (0.24) | (0.02) | |
Capex per Share |
(0.27) | (0.24) | (0.19) | (0.19) | |
Capex to Sales |
0.05 | 0.04 | 0.03 | 0.03 |
Columns are period end dates